| Financial Year |
March 31 2023 |
| Monetary Funds |
411,150,342.93 |
| Held-for-trading Financial Assets |
25,177,783.46 |
| Notes Receivable |
50,000.00 |
| Accounts Receivable |
155,460,956.69 |
| Advances to Suppliers |
65,613,915.70 |
| Other Receivables |
5,657,671.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
910,337,317.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,146,136.17 |
| Total Current Assets |
1,584,594,124.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
130,218,253.99 |
| Fixed Assetes |
133,491,927.54 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,903,772.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,315,776.26 |
| Deferred Income Tax Assets |
11,841,908.90 |
| Other Non-Current Assets |
146,077.39 |
| Sub-Total of Non-Current Assets |
353,869,809.71 |
| Total Assets |
1,938,463,934.06 |
| Short-Term Loans |
92,372,500.00 |
| Trading Financial liabilities |
5,094,745.00 |
| Notes Payable |
83,449,178.27 |
| Accounts Payable |
219,499,240.86 |
| Accounts Received In Advance |
22,970,985.00 |
| Employee Compensation Payable |
16,246,766.79 |
| Taxes Payable |
10,937,874.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,439,340.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,118,063.66 |
| Other Current Liabilities |
32,810,522.55 |
| Sub-Total of Current Liabilities |
1,194,261,913.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,080.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,587,199.98 |
| Total Liabilities |
1,229,849,113.25 |
| Paid-In Capital(Or Share Stock) |
296,400,000.00 |
| Capital Surplus |
90,083,188.96 |
| Surplus Reserve |
46,613,596.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
242,995,001.30 |
| Minority Stockholder's Interest |
72,495,103.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
636,119,717.48 |
| Owner's Equity（Stockholder's Equity） |
708,614,820.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,938,463,934.06 |
